Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Maria A Jasnis"'
Autor:
Cristina E Rodríguez, Sara I Reidel, Elisa D Bal de Kier Joffé, Maria A Jasnis, Gabriel L Fiszman
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137920 (2015)
Multicellular tumor spheroids represent a 3D in vitro model that mimics solid tumor essential properties including assembly and development of extracellular matrix and nutrient, oxygen and proliferation gradients. In the present study, we analyze the
Externí odkaz:
https://doaj.org/article/35a404a3c41846ec9c8f2e29ee2440da
Autor:
Silvia Vanzulli, Ximena Borenstein, Gabriel L. Fiszman, Maria A. Jasnis, Ada Gabriela Blidner
Publikováno v:
Nitric Oxide. 23:234-241
Low O(2) levels in solid tumors are associated with increase in hypoxia-inducible factor 1alpha (HIF-1alpha). The present study examines functional changes involved in adaptation to hypoxia of the LMM3 mammary tumor cell line, using CoCl(2) as hypoxi
Autor:
Elisa Bal de Kier Joffé, Gabriel L. Fiszman, Maria A. Jasnis, Cristina E. Rodríguez, Sara I. Reidel
Publikováno v:
PLoS ONE
PLoS ONE, 10(9)
Repositorio Institucional del Instituto Nacional de Tecnología Industrial (INTI)
Instituto Nacional de Tecnología Industrial
instacron:INTI
PLoS ONE, Vol 10, Iss 9, p e0137920 (2015)
PLoS ONE, 10(9)
Repositorio Institucional del Instituto Nacional de Tecnología Industrial (INTI)
Instituto Nacional de Tecnología Industrial
instacron:INTI
PLoS ONE, Vol 10, Iss 9, p e0137920 (2015)
Multicellular tumor spheroids represent a 3D in vitro model that mimics solid tumor essential properties including assembly and development of extracellular matrix and nutrient, oxygen and proliferation gradients. In the present study, we analyze the
Autor:
Gabriel A. Rabinovich, Ada G. Blidner, Elisa Bal de Kier Joffé, Mariana Salatino, Maria A. Jasnis, Miriam J. Diament, Slobodanka M. Klein, Ivan D. Mascanfroni
Myeloid-derived suppressor cells (MDSCs) are key regulatory cells that control inflammation and promote tumor-immune escape. To date, no specific immunomodulatory drug has proven efficacy in targeting the expansion and/or function of these cells in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e142ce0b26d75aaab933b40a1643d7ab
http://www.jimmunol.org/content/194/7/3452.long
http://www.jimmunol.org/content/194/7/3452.long
Autor:
María Elena Sales, Laura Elizabeth Rimmaudo, Tomomi Gotoh, Eulalia de la Torre, Maria A. Jasnis, Alejandro Español, Davel L, Eugenia Sacerdote de Lustig, María Laura Ribeiro
Publikováno v:
Angiogenesis. 7:45-51
Neoangiogenesis is essential for tumor and metastasis growth, but this complex process does not follow the same activation pathway, at least in tumor cell lines originated from different murine mammary adenocarcinomas. LMM3 cells were the most potent
Autor:
L. Pasik, Maria A. Jasnis, H. Malagrino, Ana María Eiján, Alberto Casabé, Inés Piccardo, Hugo Porcella, Eugenia Sacerdote de Lustig, Eduardo Omar Sandes, María D. Riveros
Publikováno v:
Journal of Surgical Oncology. 81:203-208
Background and Objectives One of the current challenges in clinical oncology is the identification of patients with superficial transitional bladder carcinoma (TBC) at high risk of recurrence or myoinvasive disease. Recently, inducible nitric oxide s
Autor:
Davel L, Maria A. Jasnis
Publikováno v:
Oncology. 52:226-229
It is known that tumor cells activate spleen cells to induce an angiogenic response. In this report we studied whether different antigenic stimuli, other than tumor cells, were able to activate spleen lymphocytes to induce angiogenesis in syngeneic c
Autor:
Slobodanka M. Klein, J. Aguirre, Y. P. de Bonaparte, Maria A. Jasnis, Miriam J. Diament, Davel L
Publikováno v:
Tumor Biology. 15:160-165
The delayed-type hypersensitivity (DTH) response and lymphocyte-mediated angiogenesis were determined in mice bearing in vivo cultures of mammary tumor cells in diffusion chambers (DCs). Soluble tumor products which diffuse from the DCs were able to
Autor:
Gabriel L. Fiszman, Maria A. Jasnis
Publikováno v:
International Journal of Breast Cancer, Vol 2011 (2011)
International Journal of Breast Cancer
International Journal of Breast Cancer
The epidermal growth factor receptor 2 (HER2) is a tyrosine kinase overexpressed in nearly 20% to 25% of invasive breast cancers. Trastuzumab is a humanized monoclonal antibody that targets HER2. The majority of patients with metastatic breast cancer
Autor:
Gabriel L. Fiszman, Sara I. Reidel, Maria A. Jasnis, Cristina E. Rodríguez, Elisa Bal de Kier Joffé
Publikováno v:
Cancer Research. 75:349-349
HER2 is overexpressed in 20% invasive breast tumors and correlates with low free disease survival. Trastuzumab (Tz), monoclonal antibody anti HER2, is used to treat HER2+ tumors; however more than half of the patients are resistant or acquire resista